AnneMTraynorMD
Hematology • Madison, WIAssociate Professor, Medicine, University of Wisconsin Medical School
Dr. Traynor is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4910 Groton Ln
Madison, WI 53711Phone+1 608-445-1537Fax+1 608-265-8133
Education & Training
University of Iowa Hospitals and ClinicsFellowship, Hematology and Medical Oncology, 1995 - 1997
Bassett Medical CenterResidency, Internal Medicine, 1990 - 1994
University of North Carolina at Chapel Hill School of MedicineClass of 1990
Certifications & Licensure
WI State Medical License 1997 - 2023
IL State Medical License 2005 - 2014
IA State Medical License 1994 - 1998
GA State Medical License 1994 - 1995
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
Clinical Trials
- Suberoylanilide Hydroxamic Acid in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer Start of enrollment: 2005 Jun 01
- Hypofractionated Radiotherapy for Lung Cancer Start of enrollment: 2004 Jun 01
- R-(-)-Gossypol Acetic Acid, Cisplatin, and Etoposide in Treating Patients With Advanced Solid Tumors or Extensive Stage Small Cell Lung Cancer Start of enrollment: 2007 Sep 01
- Join now to see all
Publications & Presentations
PubMed
- 75 citationsPilot study of gefitinib and fulvestrant in the treatment of post-menopausal women with advanced non-small cell lung cancerAnne M. Traynor, Joan H. Schiller, Laura P. Stabile, Jill M. Kolesar, Jens C. Eickhoff
Lung Cancer. 2009-04-01 - 84 citationsPemetrexed plus gemcitabine as first-line chemotherapy for patients with peritoneal mesothelioma: Final report of a phase II trialGeorge R. Simon, Claire F. Verschraegen, Pasi A. Jänne, Corey J. Langer, A. Dowlati
Journal of Clinical Oncology. 2008-07-20 - 117 citationsDose-Limiting Toxicity After Hypofractionated Dose-Escalated Radiotherapy in Non–Small-Cell Lung CancerDonald M. Cannon, Minesh P. Mehta, Jarrod B. Adkison, Deepak Khuntia, Anne M. Traynor
Journal of Clinical Oncology. 2013-12-01
Press Mentions
Faculty Promotions at Purdue Approved by BoardApril 2nd, 2020
Biostatistics and Medical Informatics Tapped for $11.8 Million National Coordinating CenterOctober 2nd, 2019
Grant Support
- Pilot Study Of Liquid Crystal Nano-Structured Surfaces (Lc/Ns) AnalysesNational Center For Research Resources2007
- Phase II Study Of Suberoylanilide Hydroxamic Acid (SAHA) In Relapsed NsclcNational Center For Research Resources2007
- Phase II Trial Of Ps341/Dox In Metastatic Breast CancerNational Cancer Institute2006
- Stem Cell Transplant As Standard Treatment For Symptomatic Multiple MyelomaNational Center For Research Resources2000–2001
- Phase II Study Of Interleukin 12 For Plateau Phase Multiple MyelomaNational Center For Research Resources1999–2001
- Infusional 8 Chloro Cyclic AMP In Treatment Of Multiple MyelomaNational Center For Research Resources1999–2000
- Stem Cell Transplant As Standard Treatment For Multiple MyelomaNational Center For Research Resources1999
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
